Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology & Oncology Physician in Gilroy, CA
NPI: 1114169323Primary Practice Location
Global Cancer Research Institute, Inc.
9360 No Name Uno, Gilroy, CA
Primary Employer
Global Cancer Research Institute, Inc.
gcrioncology.com
HQ Phone
Get M.D. Lynne's Phone Numberphone_androidMobile
Get M.D. Lynne's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1998 - 2026
David Geffen School of Medicine at UCLA
medschool.ucla.edu
Medical School
Until 1997
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Hematology and Medical Oncology
2000 - 2003
Residency • Internal Medicine
1997 - 2000
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 261 | 958 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 79 | 307 |
| 3 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 72 | 442 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 52 | 52 |
| 5 | J7050Infusion, normal saline solution , 250 cc | 46 | 176 |
Key considerations in the preclinical development of biosimilars.
Authors: Grace Dy, Antonio Jimeno, Laura Goff, Mojun Zhu, Jennifer Diamond
Publication Date: 2021-02-26
GABAergic organization of the auditory cortex in the mustached bat (Pteronotus p. parnellii).
Authors: Winer, Jeffery A, Bui, Lynne A, Hong, Jane H, Prieto, Jorge J, Larue, David T
Journal: Hear Res
Publication Date: 2010-06-04
Lead Sponsor: BPGbio
Intervention / Treatment: DRUG: Gemcitabine, DRUG: BPM31510 Nanosuspension Injection
Lead Sponsor: Athenex, Inc.
Intervention / Treatment: DRUG: Ramucirumab, DRUG: Oraxol
Lead Sponsor: Symphony Evolution, Inc.
Intervention / Treatment: DRUG: XL999
